data_29E # _chem_comp.id 29E _chem_comp.name (3S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine _chem_comp.type NON-POLYMER _chem_comp.pdbx_type HETAIN _chem_comp.formula "C18 H19 N O S" _chem_comp.mon_nstd_parent_comp_id ? _chem_comp.pdbx_synonyms Duloxetine _chem_comp.pdbx_formal_charge 0 _chem_comp.pdbx_initial_date 2013-09-11 _chem_comp.pdbx_modified_date 2020-04-05 _chem_comp.pdbx_ambiguous_flag N _chem_comp.pdbx_release_status REL _chem_comp.pdbx_replaced_by ? _chem_comp.pdbx_replaces ? _chem_comp.formula_weight 297.415 _chem_comp.one_letter_code ? _chem_comp.three_letter_code 29E _chem_comp.pdbx_model_coordinates_details ? _chem_comp.pdbx_model_coordinates_missing_flag N _chem_comp.pdbx_ideal_coordinates_details Corina _chem_comp.pdbx_ideal_coordinates_missing_flag N _chem_comp.pdbx_model_coordinates_db_code 4MM6 _chem_comp.pdbx_subcomponent_list ? _chem_comp.pdbx_processing_site RCSB # loop_ _chem_comp_atom.comp_id _chem_comp_atom.atom_id _chem_comp_atom.alt_atom_id _chem_comp_atom.type_symbol _chem_comp_atom.charge _chem_comp_atom.pdbx_align _chem_comp_atom.pdbx_aromatic_flag _chem_comp_atom.pdbx_leaving_atom_flag _chem_comp_atom.pdbx_stereo_config _chem_comp_atom.pdbx_backbone_atom_flag _chem_comp_atom.pdbx_n_terminal_atom_flag _chem_comp_atom.pdbx_c_terminal_atom_flag _chem_comp_atom.model_Cartn_x _chem_comp_atom.model_Cartn_y _chem_comp_atom.model_Cartn_z _chem_comp_atom.pdbx_model_Cartn_x_ideal _chem_comp_atom.pdbx_model_Cartn_y_ideal _chem_comp_atom.pdbx_model_Cartn_z_ideal _chem_comp_atom.pdbx_component_atom_id _chem_comp_atom.pdbx_component_comp_id _chem_comp_atom.pdbx_ordinal 29E C C C 0 1 N N N N N N 179.031 -12.173 183.091 2.400 5.059 -0.458 C 29E 1 29E N N N 0 1 N N N N N N 177.927 -11.286 183.405 2.851 3.731 -0.021 N 29E 2 29E C1 C1 C 0 1 N N N N N N 176.732 -11.296 182.572 1.913 2.687 -0.454 C1 29E 3 29E C2 C2 C 0 1 N N N N N N 176.694 -12.574 181.742 2.415 1.322 0.019 C2 29E 4 29E C3 C3 C 0 1 N N S N N N 176.065 -12.323 180.392 1.438 0.235 -0.432 C3 29E 5 29E C14 C14 C 0 1 Y N N N N N 175.712 -13.644 179.834 1.993 -1.120 -0.074 C14 29E 6 29E S S S 0 1 Y N N N N N 176.028 -14.137 178.216 1.802 -1.915 1.483 S 29E 7 29E C17 C17 C 0 1 Y N N N N N 175.336 -15.716 178.441 2.725 -3.303 0.922 C17 29E 8 29E C16 C16 C 0 1 Y N N N N N 174.892 -15.786 179.768 3.107 -3.105 -0.341 C16 29E 9 29E C15 C15 C 0 1 Y N N N N N 175.095 -14.642 180.562 2.699 -1.902 -0.892 C15 29E 10 29E O O O 0 1 N N N N N N 174.888 -11.579 180.663 0.181 0.422 0.222 O 29E 11 29E C4 C4 C 0 1 Y N N N N N 174.289 -10.878 179.663 -0.916 -0.089 -0.393 C4 29E 12 29E C13 C13 C 0 1 Y N N N N N 172.807 -10.799 179.582 -2.203 0.159 0.130 C13 29E 13 29E C12 C12 C 0 1 Y N N N N N 171.970 -11.425 180.495 -2.383 0.933 1.286 C12 29E 14 29E C11 C11 C 0 1 Y N N N N N 170.593 -11.290 180.319 -3.640 1.152 1.761 C11 29E 15 29E C10 C10 C 0 1 Y N N N N N 170.034 -10.552 179.271 -4.754 0.618 1.116 C10 29E 16 29E C9 C9 C 0 1 Y N N N N N 170.839 -9.914 178.335 -4.616 -0.138 -0.008 C9 29E 17 29E C8 C8 C 0 1 Y N N N N N 172.217 -10.018 178.465 -3.335 -0.384 -0.527 C8 29E 18 29E C7 C7 C 0 1 Y N N N N N 173.067 -9.402 177.556 -3.154 -1.160 -1.686 C7 29E 19 29E C6 C6 C 0 1 Y N N N N N 174.455 -9.506 177.678 -1.898 -1.379 -2.163 C6 29E 20 29E C5 C5 C 0 1 Y N N N N N 175.063 -10.227 178.709 -0.783 -0.843 -1.524 C5 29E 21 29E H1 H1 H 0 1 N N N N N N 179.839 -12.027 183.823 2.332 5.080 -1.546 H1 29E 22 29E H2 H2 H 0 1 N N N N N N 178.685 -13.217 183.130 1.421 5.270 -0.029 H2 29E 23 29E H3 H3 H 0 1 N N N N N N 179.406 -11.949 182.081 3.113 5.813 -0.124 H3 29E 24 29E H4 H4 H 0 1 N N N N N N 178.289 -10.354 183.382 2.984 3.706 0.979 H4 29E 25 29E H6 H6 H 0 1 N N N N N N 176.747 -10.425 181.901 0.930 2.882 -0.025 H6 29E 26 29E H7 H7 H 0 1 N N N N N N 175.839 -11.250 183.213 1.842 2.691 -1.542 H7 29E 27 29E H8 H8 H 0 1 N N N N N N 176.106 -13.334 182.278 3.398 1.128 -0.410 H8 29E 28 29E H9 H9 H 0 1 N N N N N N 177.721 -12.940 181.598 2.487 1.317 1.107 H9 29E 29 29E H10 H10 H 0 1 N N N N N N 176.758 -11.781 179.732 1.298 0.296 -1.512 H10 29E 30 29E H11 H11 H 0 1 N N N N N N 175.262 -16.496 177.698 2.949 -4.181 1.509 H11 29E 31 29E H12 H12 H 0 1 N N N N N N 174.418 -16.673 180.162 3.688 -3.829 -0.893 H12 29E 32 29E H13 H13 H 0 1 N N N N N N 174.807 -14.556 181.599 2.936 -1.618 -1.907 H13 29E 33 29E H14 H14 H 0 1 N N N N N N 172.373 -11.999 181.316 -1.529 1.353 1.797 H14 29E 34 29E H15 H15 H 0 1 N N N N N N 169.931 -11.775 181.021 -3.776 1.748 2.651 H15 29E 35 29E H16 H16 H 0 1 N N N N N N 168.960 -10.477 179.188 -5.740 0.806 1.514 H16 29E 36 29E H17 H17 H 0 1 N N N N N N 170.402 -9.350 177.524 -5.488 -0.546 -0.497 H17 29E 37 29E H18 H18 H 0 1 N N N N N N 172.648 -8.832 176.740 -4.008 -1.583 -2.194 H18 29E 38 29E H19 H19 H 0 1 N N N N N N 175.080 -9.011 176.949 -1.764 -1.975 -3.054 H19 29E 39 29E H20 H20 H 0 1 N N N N N N 176.140 -10.279 178.765 0.203 -1.033 -1.924 H20 29E 40 # loop_ _chem_comp_bond.comp_id _chem_comp_bond.atom_id_1 _chem_comp_bond.atom_id_2 _chem_comp_bond.value_order _chem_comp_bond.pdbx_aromatic_flag _chem_comp_bond.pdbx_stereo_config _chem_comp_bond.pdbx_ordinal 29E C7 C6 DOUB Y N 1 29E C7 C8 SING Y N 2 29E C6 C5 SING Y N 3 29E S C17 SING Y N 4 29E S C14 SING Y N 5 29E C9 C8 DOUB Y N 6 29E C9 C10 SING Y N 7 29E C17 C16 DOUB Y N 8 29E C8 C13 SING Y N 9 29E C5 C4 DOUB Y N 10 29E C10 C11 DOUB Y N 11 29E C13 C4 SING Y N 12 29E C13 C12 DOUB Y N 13 29E C4 O SING N N 14 29E C16 C15 SING Y N 15 29E C14 C3 SING N N 16 29E C14 C15 DOUB Y N 17 29E C11 C12 SING Y N 18 29E C3 O SING N N 19 29E C3 C2 SING N N 20 29E C2 C1 SING N N 21 29E C1 N SING N N 22 29E C N SING N N 23 29E C H1 SING N N 24 29E C H2 SING N N 25 29E C H3 SING N N 26 29E N H4 SING N N 27 29E C1 H6 SING N N 28 29E C1 H7 SING N N 29 29E C2 H8 SING N N 30 29E C2 H9 SING N N 31 29E C3 H10 SING N N 32 29E C17 H11 SING N N 33 29E C16 H12 SING N N 34 29E C15 H13 SING N N 35 29E C12 H14 SING N N 36 29E C11 H15 SING N N 37 29E C10 H16 SING N N 38 29E C9 H17 SING N N 39 29E C7 H18 SING N N 40 29E C6 H19 SING N N 41 29E C5 H20 SING N N 42 # loop_ _pdbx_chem_comp_descriptor.comp_id _pdbx_chem_comp_descriptor.type _pdbx_chem_comp_descriptor.program _pdbx_chem_comp_descriptor.program_version _pdbx_chem_comp_descriptor.descriptor 29E SMILES ACDLabs 12.01 O(c1cccc2c1cccc2)C(c3sccc3)CCNC 29E InChI InChI 1.03 InChI=1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1 29E InChIKey InChI 1.03 ZEUITGRIYCTCEM-KRWDZBQOSA-N 29E SMILES_CANONICAL CACTVS 3.385 CNCC[C@H](Oc1cccc2ccccc12)c3sccc3 29E SMILES CACTVS 3.385 CNCC[CH](Oc1cccc2ccccc12)c3sccc3 29E SMILES_CANONICAL "OpenEye OEToolkits" 1.7.6 CNCC[C@@H](c1cccs1)Oc2cccc3c2cccc3 29E SMILES "OpenEye OEToolkits" 1.7.6 CNCCC(c1cccs1)Oc2cccc3c2cccc3 # loop_ _pdbx_chem_comp_identifier.comp_id _pdbx_chem_comp_identifier.type _pdbx_chem_comp_identifier.program _pdbx_chem_comp_identifier.program_version _pdbx_chem_comp_identifier.identifier 29E "SYSTEMATIC NAME" ACDLabs 12.01 (3S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine 29E "SYSTEMATIC NAME" "OpenEye OEToolkits" 1.7.6 (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1-amine # loop_ _pdbx_chem_comp_audit.comp_id _pdbx_chem_comp_audit.action_type _pdbx_chem_comp_audit.date _pdbx_chem_comp_audit.processing_site 29E 'Create component' 2013-09-11 RCSB 29E 'Initial release' 2013-10-16 RCSB 29E 'Modify synonyms' 2020-04-05 RCSB # _pdbx_chem_comp_synonyms.ordinal 1 _pdbx_chem_comp_synonyms.comp_id 29E _pdbx_chem_comp_synonyms.name Duloxetine _pdbx_chem_comp_synonyms.provenance AUTHOR _pdbx_chem_comp_synonyms.type ? # _pdbe_chem_comp_drugbank_details.comp_id 29E _pdbe_chem_comp_drugbank_details.drugbank_id DB00476 _pdbe_chem_comp_drugbank_details.type 'small molecule' _pdbe_chem_comp_drugbank_details.name Duloxetine _pdbe_chem_comp_drugbank_details.description 'Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686.[A178741] Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.[L6454] It has since received approval for a variety of indications including the treatment of neuropathic pain, Generalized Anxiety disorder, osteoarthritis, and stress incontinence. Duloxetine continues to be investigated for the treatment of pain in cancer, surgery, and more.' _pdbe_chem_comp_drugbank_details.cas_number 116539-59-4 _pdbe_chem_comp_drugbank_details.mechanism_of_action "Duloxetine is a potent inhibitor of neuronal serotonin and norepinephrine reuptake and a less potent inhibitor of dopamine reuptake.[A178714] Duloxetine has no significant affinity for dopaminergic, adrenergic, cholinergic, histaminergic, opioid, glutamate, and GABA receptors. Action on the external urinary sphincter is mediated via duloxetine's CNS effects. Increased serotonin and norepinephrine concentrations in Onuf's nucleus leads to increased activation of 5-HT2, 5-HT3, and α1 adrenergic receptors.[A178663,A178666] 5-HT2 and α1 are both Gq coupled and their activation increases the activity of the inositol trisphosphate/phospholipase C (IP3/PLC) pathway.[T116] This pathway leads to release of intracellular calcium stores, increasing intracellular calcium concentrations, and facilitating neuronal excitability. 5-HT3 functions as a ligand-gated sodium channel which allows sodium to flow into the neuron when activated. Increased flow of sodium into the neuron contributes to depolarization and activation of voltage gated channels involved in action potential generation. The combined action of these three receptors contributes to increased excitability of the pudendal motor nerve in response to glutamate. Also related to duloxetine's action at the spinal cord is its modulation of pain. Increasing the concentration of serotonin and norepinephrine in the dorsal horn of the spinal cord increases descending inhibition of pain through activation of 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2, 5-HT3, α1-adrenergic, and α2-adrenergic receptors.[A178705] 5-HT2, 5-HT3, and α1-adrenergic mediate neuronal activation as described above. The activated neuron in this case is the GABAergic inhibitory interneuron which synapses onto the nociceptive projection neuron to inhibit the transmission of painful stimuli to the brain. The 5-HT1 and α2 receptors are Gi/Go coupled and their activation leads to increased potassium current through inward rectifier channels and decreased adenylyl cyclase/protein kinase A signaling which contributes to neuronal inhibition.[A178705,T116] These inhibitory receptors are present on the projection neuron itself as well as the dorsal root ganglion which precedes it and serves to directly suppress the transmission of painful stimuli. The mechanisms involved in duloxetine's benefits in depression and anxiety have not been fully elucidated. Dysfunctional serotonin and norepinephrine signaling are thought to be involved and increases in the availability of these neurotransmitters at the synaptic cleft thought to mediate a therapeutic effect.[A178666] It is postulated that the involvement of serotonin and norepinephrine in area responsible for emotional modulation such as the limbic system contributes to the effects in mood disorders specifically but this has yet to be confirmed. Duloxetine's hypertensive effect is related to its intended pharmacological effect. Increased availability of norepinephrine leads to activation of adrenergic receptors on the vascular endothelium. Since the action of α1 receptors predominates, vasoconstriction results as the Gq coupled receptor mediates calcium release from the sarcoplasmic reticulum to facilitate smooth muscle contraction.[T116]" # loop_ _pdbe_chem_comp_synonyms.comp_id _pdbe_chem_comp_synonyms.name _pdbe_chem_comp_synonyms.provenance _pdbe_chem_comp_synonyms.type 29E Duloxetine wwPDB ? 29E (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine DrugBank ? 29E (S)-duloxetine DrugBank ? 29E Duloxetine DrugBank ? 29E Dulane DrugBank 'International brand' 29E Duzela DrugBank 'International brand' # _pdbe_chem_comp_drugbank_classification.comp_id 29E _pdbe_chem_comp_drugbank_classification.drugbank_id DB00476 _pdbe_chem_comp_drugbank_classification.parent Naphthalenes _pdbe_chem_comp_drugbank_classification.kingdom 'Organic compounds' _pdbe_chem_comp_drugbank_classification.class Naphthalenes _pdbe_chem_comp_drugbank_classification.superclass Benzenoids _pdbe_chem_comp_drugbank_classification.description 'This compound belongs to the class of organic compounds known as naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings.' # loop_ _pdbe_chem_comp_drugbank_targets.comp_id _pdbe_chem_comp_drugbank_targets.drugbank_id _pdbe_chem_comp_drugbank_targets.name _pdbe_chem_comp_drugbank_targets.organism _pdbe_chem_comp_drugbank_targets.uniprot_id _pdbe_chem_comp_drugbank_targets.pharmacologically_active _pdbe_chem_comp_drugbank_targets.ordinal 29E DB00476 'Sodium-dependent serotonin transporter' Humans P31645 yes 1 29E DB00476 'Sodium-dependent noradrenaline transporter' Humans P23975 yes 2 29E DB00476 'Sodium-dependent dopamine transporter' Humans Q01959 unknown 3 # loop_ _software.name _software.version _software.description rdkit 2025.03.3 'Core functionality.' pdbeccdutils 1.0.0 'Wrapper to provide 2D templates and molecular fragments.' # loop_ _pdbe_chem_comp_atom_depiction.comp_id _pdbe_chem_comp_atom_depiction.atom_id _pdbe_chem_comp_atom_depiction.element _pdbe_chem_comp_atom_depiction.model_Cartn_x _pdbe_chem_comp_atom_depiction.model_Cartn_y _pdbe_chem_comp_atom_depiction.pdbx_ordinal 29E C C 3.000 -0.747 1 29E N N 4.299 0.003 2 29E C1 C 5.598 -0.747 3 29E C2 C 6.897 0.003 4 29E C3 C 8.196 -0.747 5 29E C14 C 8.196 -2.247 6 29E S S 6.983 -3.129 7 29E C17 C 7.446 -4.555 8 29E C16 C 8.946 -4.555 9 29E C15 C 9.410 -3.129 10 29E O O 9.495 0.003 11 29E C4 C 9.495 1.503 12 29E C13 C 10.794 2.253 13 29E C12 C 12.135 1.451 14 29E C11 C 13.494 2.222 15 29E C10 C 13.494 3.784 16 29E C9 C 12.135 4.555 17 29E C8 C 10.794 3.753 18 29E C7 C 9.495 4.503 19 29E C6 C 8.196 3.753 20 29E C5 C 8.196 2.253 21 # loop_ _pdbe_chem_comp_bond_depiction.comp_id _pdbe_chem_comp_bond_depiction.atom_id_1 _pdbe_chem_comp_bond_depiction.atom_id_2 _pdbe_chem_comp_bond_depiction.value_order _pdbe_chem_comp_bond_depiction.bond_dir _pdbe_chem_comp_bond_depiction.pdbx_ordinal 29E C7 C6 DOUBLE NONE 1 29E C7 C8 SINGLE NONE 2 29E C6 C5 SINGLE NONE 3 29E S C17 SINGLE NONE 4 29E S C14 SINGLE NONE 5 29E C9 C8 DOUBLE NONE 6 29E C9 C10 SINGLE NONE 7 29E C17 C16 DOUBLE NONE 8 29E C8 C13 SINGLE NONE 9 29E C5 C4 DOUBLE NONE 10 29E C10 C11 DOUBLE NONE 11 29E C13 C4 SINGLE NONE 12 29E C13 C12 DOUBLE NONE 13 29E C4 O SINGLE NONE 14 29E C16 C15 SINGLE NONE 15 29E C14 C3 SINGLE NONE 16 29E C14 C15 DOUBLE NONE 17 29E C11 C12 SINGLE NONE 18 29E C3 O SINGLE NONE 19 29E C3 C2 SINGLE BEGINDASH 20 29E C2 C1 SINGLE NONE 21 29E C1 N SINGLE NONE 22 29E C N SINGLE NONE 23 # loop_ _pdbe_chem_comp_substructure.comp_id _pdbe_chem_comp_substructure.substructure_name _pdbe_chem_comp_substructure.id _pdbe_chem_comp_substructure.substructure_type _pdbe_chem_comp_substructure.substructure_smiles _pdbe_chem_comp_substructure.substructure_inchis _pdbe_chem_comp_substructure.substructure_inchikeys 29E MurckoScaffold S1 scaffold c1csc(COc2cccc3ccccc23)c1 InChI=1S/C15H12OS/c1-2-8-14-12(5-1)6-3-9-15(14)16-11-13-7-4-10-17-13/h1-10H,11H2 RJYZOLZRGXQTAS-UHFFFAOYSA-N 29E napthalene F1 fragment c1ccc2ccccc2c1 InChI=1S/C10H8/c1-2-6-10-8-4-3-7-9(10)5-1/h1-8H UFWIBTONFRDIAS-UHFFFAOYSA-N 29E phenyl F2 fragment c1ccccc1 InChI=1S/C6H6/c1-2-4-6-5-3-1/h1-6H UHOVQNZJYSORNB-UHFFFAOYSA-N 29E thiophen F3 fragment c1ccsc1 InChI=1S/C4H4S/c1-2-4-5-3-1/h1-4H YTPLMLYBLZKORZ-UHFFFAOYSA-N # loop_ _pdbe_chem_comp_substructure_mapping.comp_id _pdbe_chem_comp_substructure_mapping.atom_id _pdbe_chem_comp_substructure_mapping.substructure_id _pdbe_chem_comp_substructure_mapping.substructure_ordinal 29E C3 S1 1 29E C14 S1 1 29E S S1 1 29E C17 S1 1 29E C16 S1 1 29E C15 S1 1 29E O S1 1 29E C4 S1 1 29E C13 S1 1 29E C12 S1 1 29E C11 S1 1 29E C10 S1 1 29E C9 S1 1 29E C8 S1 1 29E C7 S1 1 29E C6 S1 1 29E C5 S1 1 29E C11 F1 1 29E C10 F1 1 29E C9 F1 1 29E C8 F1 1 29E C13 F1 1 29E C12 F1 1 29E C4 F1 1 29E C5 F1 1 29E C6 F1 1 29E C7 F1 1 29E C4 F2 1 29E C5 F2 1 29E C6 F2 1 29E C7 F2 1 29E C8 F2 1 29E C13 F2 1 29E C13 F2 2 29E C8 F2 2 29E C9 F2 2 29E C10 F2 2 29E C11 F2 2 29E C12 F2 2 29E C14 F3 1 29E C15 F3 1 29E C16 F3 1 29E C17 F3 1 29E S F3 1 # _pdbe_chem_comp_rdkit_properties.comp_id 29E _pdbe_chem_comp_rdkit_properties.exactmw 297.119 _pdbe_chem_comp_rdkit_properties.amw 297.423 _pdbe_chem_comp_rdkit_properties.lipinskiHBA 2 _pdbe_chem_comp_rdkit_properties.lipinskiHBD 1 _pdbe_chem_comp_rdkit_properties.NumRotatableBonds 7 _pdbe_chem_comp_rdkit_properties.NumHBD 1 _pdbe_chem_comp_rdkit_properties.NumHBA 3 _pdbe_chem_comp_rdkit_properties.NumHeavyAtoms 21 _pdbe_chem_comp_rdkit_properties.NumAtoms 40 _pdbe_chem_comp_rdkit_properties.NumHeteroatoms 3 _pdbe_chem_comp_rdkit_properties.NumAmideBonds 0 _pdbe_chem_comp_rdkit_properties.FractionCSP3 0.222 _pdbe_chem_comp_rdkit_properties.NumRings 3 _pdbe_chem_comp_rdkit_properties.NumAromaticRings 3 _pdbe_chem_comp_rdkit_properties.NumAliphaticRings 0 _pdbe_chem_comp_rdkit_properties.NumSaturatedRings 0 _pdbe_chem_comp_rdkit_properties.NumHeterocycles 1 _pdbe_chem_comp_rdkit_properties.NumAromaticHeterocycles 1 _pdbe_chem_comp_rdkit_properties.NumSaturatedHeterocycles 0 _pdbe_chem_comp_rdkit_properties.NumAliphaticHeterocycles 0 _pdbe_chem_comp_rdkit_properties.NumSpiroAtoms 0 _pdbe_chem_comp_rdkit_properties.NumBridgeheadAtoms 0 _pdbe_chem_comp_rdkit_properties.NumAtomStereoCenters 1 _pdbe_chem_comp_rdkit_properties.NumUnspecifiedAtomStereoCenters 0 _pdbe_chem_comp_rdkit_properties.labuteASA 155.686 _pdbe_chem_comp_rdkit_properties.tpsa 21.260 _pdbe_chem_comp_rdkit_properties.CrippenClogP 3.685 _pdbe_chem_comp_rdkit_properties.CrippenMR 87.098 _pdbe_chem_comp_rdkit_properties.chi0v 11.080 _pdbe_chem_comp_rdkit_properties.chi1v 6.330 _pdbe_chem_comp_rdkit_properties.chi2v 2.990 _pdbe_chem_comp_rdkit_properties.chi3v 2.990 _pdbe_chem_comp_rdkit_properties.chi4v 1.955 _pdbe_chem_comp_rdkit_properties.chi0n 29.264 _pdbe_chem_comp_rdkit_properties.chi1n 14.961 _pdbe_chem_comp_rdkit_properties.chi2n 2.294 _pdbe_chem_comp_rdkit_properties.chi3n 2.294 _pdbe_chem_comp_rdkit_properties.chi4n 1.463 _pdbe_chem_comp_rdkit_properties.hallKierAlpha -1.840 _pdbe_chem_comp_rdkit_properties.kappa1 3.918 _pdbe_chem_comp_rdkit_properties.kappa2 6.743 _pdbe_chem_comp_rdkit_properties.kappa3 3.257 _pdbe_chem_comp_rdkit_properties.Phi 1.258 # loop_ _pdbe_chem_comp_external_mappings.comp_id _pdbe_chem_comp_external_mappings.source _pdbe_chem_comp_external_mappings.resource _pdbe_chem_comp_external_mappings.resource_id 29E UniChem DrugBank DB00476 29E UniChem 'Guide to Pharmacology' 202 29E UniChem ChEBI 36795 29E UniChem NIH SAM001247059 29E UniChem ZINC ZINC000001536779 29E UniChem eMolecules 2729002 29E UniChem fdasrs O5TNM5N07U 29E UniChem PharmGKB PA10066 29E UniChem HMDB HMDB0014619 29E UniChem BindingDb 84745 29E UniChem 'EPA CompTox Dashboard' DTXSID6048385 29E UniChem DrugCentral 972 29E UniChem BRENDA 167769 29E UniChem ChemicalBook CB8670379 29E UniChem DailyMed DULOXETINE 29E UniChem ClinicalTrials ARICLAIM 29E UniChem ClinicalTrials CYMBALTA 29E UniChem ClinicalTrials 'DRIZALMA SPRINKLE' 29E UniChem ClinicalTrials DULOXETINE 29E UniChem ClinicalTrials 'DULOXETINE HYDROCHLORIDE' 29E UniChem ClinicalTrials LY-248686 29E UniChem ClinicalTrials LY248686 29E UniChem ClinicalTrials XERISTAR 29E UniChem ClinicalTrials YENTREVE 29E UniChem rxnorm CYMBALTA 29E UniChem rxnorm DULOXETINE 29E UniChem rxnorm 'DULOXETINE HYDROCHLORIDE' 29E UniChem MedChemExpress HY-B0161 29E UniChem 'Probes And Drugs' PD003013 29E UniChem Nikkaji J550.708A 29E UniChem SureChEMBL SCHEMBL8291 29E UniChem 'PubChem TPHARMA' 14849439 29E UniChem 'PubChem TPHARMA' 14873633 29E UniChem PubChem 60835 29E UniChem LINCS LSM-3591 29E UniChem ACTor 116539-59-4 # loop_ _pdbe_chem_comp_rdkit_conformer.comp_id _pdbe_chem_comp_rdkit_conformer.atom_id _pdbe_chem_comp_rdkit_conformer.Cartn_x_rdkit _pdbe_chem_comp_rdkit_conformer.Cartn_y_rdkit _pdbe_chem_comp_rdkit_conformer.Cartn_z_rdkit _pdbe_chem_comp_rdkit_conformer.rdkit_method _pdbe_chem_comp_rdkit_conformer.rdkit_ordinal 29E C 2.864 -2.636 1.349 ETKDGv3 1 29E N 2.815 -1.348 2.046 ETKDGv3 2 29E C1 1.705 -0.514 1.562 ETKDGv3 3 29E C2 2.132 0.284 0.323 ETKDGv3 4 29E C3 1.084 1.328 -0.111 ETKDGv3 5 29E C14 1.666 2.173 -1.207 ETKDGv3 6 29E S 1.746 1.707 -2.924 ETKDGv3 7 29E C17 2.639 3.182 -3.363 ETKDGv3 8 29E C16 2.843 3.919 -2.274 ETKDGv3 9 29E C15 2.295 3.336 -1.029 ETKDGv3 10 29E O -0.087 0.685 -0.626 ETKDGv3 11 29E C4 -1.224 0.261 0.090 ETKDGv3 12 29E C13 -2.211 -0.598 -0.611 ETKDGv3 13 29E C12 -2.041 -0.977 -1.891 ETKDGv3 14 29E C11 -3.047 -1.836 -2.550 ETKDGv3 15 29E C10 -4.131 -2.242 -1.877 ETKDGv3 16 29E C9 -4.326 -1.833 -0.472 ETKDGv3 17 29E C8 -3.416 -1.052 0.132 ETKDGv3 18 29E C7 -3.579 -0.626 1.532 ETKDGv3 19 29E C6 -2.658 0.153 2.107 ETKDGv3 20 29E C5 -1.456 0.612 1.373 ETKDGv3 21 29E H1 3.706 -3.238 1.751 ETKDGv3 22 29E H2 3.040 -2.490 0.263 ETKDGv3 23 29E H3 1.922 -3.208 1.503 ETKDGv3 24 29E H4 2.644 -1.553 3.058 ETKDGv3 25 29E H6 1.428 0.206 2.363 ETKDGv3 26 29E H7 0.807 -1.132 1.340 ETKDGv3 27 29E H8 2.322 -0.411 -0.522 ETKDGv3 28 29E H9 3.087 0.806 0.559 ETKDGv3 29 29E H10 0.837 2.005 0.732 ETKDGv3 30 29E H11 2.973 3.447 -4.357 ETKDGv3 31 29E H12 3.374 4.862 -2.298 ETKDGv3 32 29E H13 2.408 3.806 -0.061 ETKDGv3 33 29E H14 -1.173 -0.664 -2.458 ETKDGv3 34 29E H15 -2.905 -2.137 -3.580 ETKDGv3 35 29E H16 -4.866 -2.872 -2.361 ETKDGv3 36 29E H17 -5.208 -2.170 0.060 ETKDGv3 37 29E H18 -4.445 -0.940 2.102 ETKDGv3 38 29E H19 -2.791 0.460 3.136 ETKDGv3 39 29E H20 -0.774 1.243 1.919 ETKDGv3 40 #